The effect of lanthanum carbonate on hyperphosphatemia in chronic kidney disease patients not on dialysis.

Not Applicable

• Conditions: non-dialysis chronic kidney disease

• Registration Number: JPRN-UMIN000015223
• Lead Sponsor: Wakayama Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-10-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 140

Inclusion Criteria

Not provided

Exclusion Criteria

1)<20years old 2)Malignancy of any type 3)Contraindications to lanthanum carbonate 4)Diabetes mellitus 5)Renal transplant 6)Pregnant or breast-feeding women 7)Ineligible patients for this study according to the investigator's judgment

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change from baseline and compare between 2 groups, as follow items : FGF23, alfa-Klotho and sclerostin (at 2 months)

Secondary Outcome Measures

Name	Time	Method
Change from baseline and compare between 2 groups, as follows: Phosphate, Calcium, Phosphate excretion in urine, iPTH, wPTH (at 2 months) delta-FGF23, eGFR, 1/Cr, Cr, iPTH, wPTH, BAP, TRACP-5b, OPG, Mg (at 12 months)